Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14026 - 14050 of 14556 in total
BMS-564929 is an investigational therapeutic agent built to be a selective androgen receptor modulator (SARM). So far, it has been developed by Bristol-Myers Squibb for the symptomatic treatment of andropause.
Experimental
Experimental
Experimental
Investigational
MK-4965 is an HIV-1 reverse transcriptase inhibitor.
Experimental
Evatanepag has been used in trials studying the treatment of Tibial Fractures.
Investigational
Iguratimod is under investigation in Rheumatoid Arthritis.
Investigational
A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by...
Experimental
Matched Description: … It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. …
Displaying drugs 14026 - 14050 of 14556 in total